The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.09BCNY
461.80M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
388.94MCNY
58.08M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-99.23%
Updated Sep 21, 2026
Beta
0.5680x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-16.36%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
3.09BCNY
461.80M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
5.74BCNY
856.77M · vs all stocks (USD)
Updated Sep 21, 2026
Price to Sales (TTM)
7.57x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 7.95×.Updated Sep 21, 2026
Price to Book (MRQ)
0.8436x
Updated Sep 21, 2026
Enterprise to Revenue
14.75x
Updated Sep 21, 2026
Enterprise to EBITDA
-56.17x
Updated Sep 21, 2026
Gross Margin
-13.15%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -28.95%.Updated Sep 21, 2026
Profit Margin
-99.23%
Updated Sep 21, 2026
Operating Margin
-40.17%
Updated Sep 21, 2026
Return on Assets (TTM)
-1.82%
Updated Sep 21, 2026
Return on Equity (TTM)
-10.10%
Updated Sep 21, 2026
Revenue (TTM)
388.94MCNY
58.08M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
0.2920CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
27.00%
Updated Sep 21, 2026
Gross Profit (TTM)
-112.62MCNY
-16.82M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
-102.14MCNY
-15.25M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-385.95MCNY
-57.63M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
27.00%
Updated Sep 21, 2026
Operating Cash Flow (TTM)
-177.74MCNY
-26.54M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-34.96MCNY
-5.22M · vs all stocks (USD)
Updated Sep 21, 2026
Payout Ratio
0.00%
Updated Sep 21, 2026
Minority Interest (Equity)
57.09MCNYFY2025 · Dec 31, 2025
Revenue
376.74MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
452.21MCNYFY2025 · Dec 31, 2025
Gross Profit
-75.47MCNYFY2025 · Dec 31, 2025
Operating Income
-144.83MCNY
-21.63M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-385.17MCNYFY2025 · Dec 31, 2025
Income Tax Expense
807.94KCNYFY2025 · Dec 31, 2025
Net Income
-385.98MCNYFY2025 · Dec 31, 2025
EBIT
-303.99MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-27.05MCNYFY2025 · Dec 31, 2025
Research & Development
8.62MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
25.59MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.32MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.58MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
81.19MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.33BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.33BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-385.98MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.38MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-414.96MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-418.48MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
354.36MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-385.98MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
84.43MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-32.87MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-80.53MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.52MCNYFY2025 · Dec 31, 2025
Net Acquisitions
13.56MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-418.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
504.60MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
96.64MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.21BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.06BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-49.29MCNYFY2025 · Dec 31, 2025
Other Financing Charges
101.42MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
197.06MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.34BSharesUpdated Sep 21, 2026
Float Shares
791.05MSharesUpdated Sep 21, 2026
% Held by Insiders
44.16%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
0.04%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
537.60MCNY
80.28M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
0.4010CNYUpdated Sep 21, 2026
Total Debt (MRQ)
3.15BCNY
469.79M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.8567x
Updated Sep 21, 2026
Current Ratio (MRQ)
1.98x
Updated Sep 21, 2026
Book Value per Share (MRQ)
2.60CNYUpdated Sep 21, 2026
Total Assets
6.66BCNY
994.26M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.33BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.99BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.33BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.30BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.69BCNYFY2025 · Dec 31, 2025
Cash
354.36MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.11KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
354.37MCNYFY2025 · Dec 31, 2025
Accounts Receivable
77.75MCNYFY2025 · Dec 31, 2025
Inventory
3.80BCNYFY2025 · Dec 31, 2025
Accounts Payable
91.28MCNYFY2025 · Dec 31, 2025
Short-term Debt
735.85MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
403.96MCNYFY2025 · Dec 31, 2025
Long-term Debt
961.04MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
2.50MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.34BCNYFY2025 · Dec 31, 2025
Retained Earnings
1.12BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.67BCNY
547.85M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
10.05MCNYFY2025 · Dec 31, 2025
52-Week Low
2.15CNYUpdated Sep 21, 2026
52-Week High
4.72CNYUpdated Sep 21, 2026
52-Week Change
-16.36%
vs all stocks
Updated Sep 21, 2026
Beta
0.5680x
vs all stocks
Updated Sep 21, 2026
50-Day MA
2.90CNYUpdated Sep 21, 2026
200-Day MA
3.44CNYUpdated Sep 21, 2026
Avg 10-Day Volume
51.85MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
28.67MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.2900CNYUpdated Sep 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.